Fidji Simo steps down from OpenAI's No. 2 role

The most human line in Fidji Simo's departure is also its most quietly devastating. In her own statement she framed the decision not as a strategic pivot but as an overdue reckoning: "I am only making this decision now because I failed to make it many times before" ^[1]. Simo has lived with postural orthostatic tachycardia syndrome (POTS), a neuroimmune condition, since 2019, when she received the diagnosis after a roughly three-year search for answers ^[2]. For seven years she carried it through some of the most demanding jobs in tech, running the Facebook app, taking Instacart public, and then joining OpenAI as its No. 2 ^[2].

The breaking point came this spring. Simo went on medical leave in April 2026 after a severe flare-up, and roughly three months of that leave made clear her recovery would take far longer and be more complex than expected ^[1]. Rather than a clean corporate handoff, this reads as the story of a high-performing leader who repeatedly ignored advice to slow down and is only now, under duress, choosing her health over the job her career had been building toward ^[1]. It is a rare public admission from an executive at the very top of the AI industry that ambition and chronic illness cannot be indefinitely reconciled.

When OpenAI hired Simo in 2025 as its first CEO of Applications, it built a two-headed leadership design: Altman on research and compute, Simo on revenue and product ^[3]. She reported directly to Altman and was widely seen as a likely candidate to take on even more responsibility once OpenAI went public ^[4]. That made her the closest thing the company had to an heir apparent, and it is precisely why her exit stings.

Rather than name a single successor, OpenAI is distributing her duties across President Greg Brockman, CFO Sarah Friar, and Chief Strategy Officer Jason Kwon ^[5]. Brockman had already been overseeing product during her leave, so the split formalizes an arrangement that has been improvised since April ^[6]. Splitting one person's remit across three executives is what companies do when there is no obvious next-in-line, and TechCrunch put the implication bluntly: OpenAI's executive ranks "appear from the outside to be on the thin side" ^[4]. For a company that has spent two years shedding senior leaders, the absence of a clean successor is the story underneath the story.

The departure lands at an awkward moment. OpenAI is eyeing a possible IPO and racing to close the enterprise gap with Anthropic, and stable management is exactly the kind of signal investors want to see before a public offering ^[4]. Losing the executive who owned the revenue and product side, right as the company tries to prove it can operate like a durable business rather than a research lab, removes a reassurance the IPO narrative was leaning on ^[7].

More structurally, Simo's exit unwinds the deliberate separation of powers OpenAI built around her. The dual-CEO design was meant to let Altman focus on research and compute while a seasoned operator ran the money-making applications ^[3]. With her duties folded back into Brockman and the founder circle, the org tilts back toward its founder, research, and engineering axis - the very center of gravity the Simo hire was supposed to counterbalance ^[5]. In effect, OpenAI is reverting to a more concentrated, product-and-research-led shape at the exact moment a diversified executive bench would be most valuable.

Public reaction split cleanly along two lines. On X, the response was overwhelmingly sympathetic, with the conversation centered on health and gratitude rather than corporate maneuvering; the highest-engagement posts were the human ones - Simo's own disclosure and Altman's personal note calling the situation painful and wishing her a fast recovery ^[1]. Notably, the business-transition angle drew far less attention than the personal one.

The more analytical read surfaced on Reddit, where sentiment fractured between genuine sympathy and darker gallows humor. The sharpest strategic comment cut through both: this is a genuinely health-driven departure, not an obvious boardroom coup, but it is still "strategically painful," and it points toward OpenAI tilting back to a founder, research, and product-engineering core built around Altman and Brockman. A recurring, more cynical thread questioned the optics of a leader who publicly championed productivity being overworked into a relapse, and another noted the news was landing beneath a busy model-release cycle. One caution worth flagging: some community threads wrongly conflated Simo with a separate OpenAI executive's unrelated health matter, an error that was corrected in the discussion and should not be repeated.